标普和纳斯达克内在价值 联系我们

Ra Medical Systems, Inc. RMED NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
31/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Ra Medical Systems, Inc. (RMED) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 30/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score
31/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
20/100
Analyst consensus
→ Forecast
过去
0/100
→ Income
健康
17/100
Debt-to-Equity & liquidity
→ Health
~
护城河
50/100
→ Income
成长
90/100
→ Income
收入
10/100
→ Income

估值概览 — RMED

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率783.74
EV/EBITDA0.0
每股数据
EPS (TTM)$-15.90
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2016 $-433.96 $5.98M $-4.2M -70.3%
2017 $-1,834.66 $5.87M $-17.77M -302.6%
2018 $-4,175.51 $6.26M $-30.83M -492.8%
2019 $-5,416.22 $7.2M $-56.96M -791.2%
2020 $-1,060.77 $4.41M $-36.05M -818.3%
2021 $-269.91 $22K $-27.26M -123913.6%
2022 $-25.98 $14K $-26.87M -191892.9%
2024 $-6.68 $420K $-21.8M -5190.7%
2025 $-15.90 $819K $-17.18M -2098%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言